Connect with us

Cannabis News

Former Senator Details Psychedelics Conversations With Two Trump Cabinet Members

Published

on

A former US senator says he has personally spoken with the heads of the US Department of Health and Human Services (HHS) and the US Department of Veterans Affairs (VA) about the therapeutic potential of psychedelics such as ibogaine, and both members of President Donald Trump’s cabinet welcomed reform on the issue.

Former Sen. Kyrsten Sinema (I-AZ), who was a Democrat for most of her career in Congress before becoming an independent, said there is a great opportunity under the Trump administration to free up access to psychedelics for therapeutic purposes, Robert F. Kennedy Jr. His “close” relationship with the HHS secretary and swinging around alternative political views.

In an interview with Politico, Sinema spoke about the country’s “magical and unique time” for psychedelic reform at a recent event hosted by Americans for Ibogaine, the advocacy organization co-founded by former Texas Gov. Rick Perry (R).

“Is there an opportunity to do this in this administration? Hell, yes,” he said, adding that Kennedy “is disruptive and supports psychedelic medicine.”

“The opportunity is ripe in this administration, and we should strike while the iron is hot,” said the former lawmaker, who has publicized the therapeutic use of the psychedelic ibogaine.

In addition to Kennedy, Sinema said he advised VA Secretary Doug Collins about the potential of psychedelics to help veterans with serious mental health issues.

“He hadn’t heard of it. He hadn’t even heard of psychedelic medicine,” she said. “He was skeptical at first. He’s a conservative pastor in Georgia. Then he got together with some veterans and saw the science and as you’ve heard, he’s the most prominent proponent of psychedelic medicine in the administration.”

“Historically, I think you’ve seen psychedelics — not necessarily psychedelic medicine — but psychedelics, left-wing hippies dominated,” he said. say Political “Psychedelic medicine as a treatment for disorders is important to many people on the right. I want to be clear: the reason is not because they are psychedelics, but because nothing else works.”

The former senator said that “in a conservative’s brain, psychedelics are not a drug, they are a medicine.”

“In the old-school left-wing psychedelic movement, they’re seen as a drug. That drug has medicinal properties, but it also has other non-medicinal properties that they celebrate,” he said. “I think what you’re seeing from the mainstream blue community is a concern that if they accept psychedelics they’ll look like left-wing weirdos and hippies. It could also be a commitment to mainstream medicine. Politically speaking, it could also be skepticism if conservatives like it.”

As the Arizona legislature advanced an ibogaine research project earlier this year, the former senator—who also championed psychedelic legislation while serving in Congress—.he gathered support for the reformWhile pledging to personally raise $5 million in philanthropic donations to support psychedelic research, if it ultimately materializes.

Last year, a US Department of Veterans Affairs (VA) official, who has since moved into an advisory role, praised Sinema. his “knowledge of psychedelic literature and all related subjects” while praising the agency’s work to advance research into novel therapies.

For his part, Kennedy, the health secretary, he is believed to still use psychedelics, although he is otherwise soberThe following book by a journalist who allegedly had a romantic relationship with her states.

Last month, Kennedy, Vice President JD Vance, the Food and Drug Administration (FDA) commissioner and other Trump administration officials attended the “Make America Healthy Again” summit. it was a session dedicated to studying psychedelic medicine.

While Sinema noted that Collins was not particularly familiar with psychedelic therapy before joining the Trump administration, the secretary has become one of the most vocal advocates for advancing reform to ease access for veterans.

In July, for example, VA Secretary He proclaimed his mission to promote access to psychedelics for veterans with serious mental health conditions, it was possible to say that it “opened that door wider than most probably thought”.

“I’m the first secretary of the VA—actually, in a cabinet about a month and a half ago— really brought psychedelics to a Cabinet meeting” Collins said at the time. “I think what we need to look at is we need to put the alternatives on the map. The VA will do our job. We will do it within the law and we will do what we have to do.”

The secretary also said in the summer “very open” to expanding access to psychedelic therapy for veterans-he emphasized that he intends to find ways to “cure” people with serious mental illnesses and not just to treat superficial symptoms.

Collins noted that the VA is actively conducting a dozen or so clinical trials either internally or through private partnerships “on a number of different substances where we’re seeing really good results,” among others. One based at VA Bronx Health Care researching MDMA-assisted therapy “Actually, with very good results.”


It’s Marijuana Moment tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.


Learn more about our marijuana bill tracking and become a Patreon supporter to gain access

In June, Kennedy said that his agency “Fully committed” to expanding research into the benefits of psychedelic therapy. and, along with the head of the FDA, aims to give military veterans legal access to these substances “within 12 months.”

The secretary also said that in April He had a “wonderful experience” with LSD at the age of 15He took it because he thought they would be able to see dinosaurs, as depicted in a comic he was a fan of.

Last October, Kennedy specifically criticized the FDA under the previous administration for the agency’s “eradication of psychedelics” and a laundry list of other issues that he said was a “war on public health” that would end under the Trump administration.

Photo elements courtesy of the user carlosemmaskype and Apollo.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Cannabis News

New Zealand sun-grown cannabis site earns endorsement from Columbia University scientist

Published

on

By

Not all cannabis farms are visited by a Columbia University professor. Fewer still are singled out as the best place on earth to grow the plant. That’s what happened when Colin Nuckolls, a professor of organic chemistry at Columbia and one of the most cited independent researchers on the chemistry of cannabis, visited Puro’s Kēkerengū farm on the Kaikōura Coast earlier this year.

Puro has been cultivating medicinal cannabis in Marlborough since 2018, building its model around outdoor, organically certified production at two sites in the region. Kēkerengū Farm is located on the coast with mountain protection to the west, and the company has long pointed to its environment, long hours of sunshine, ocean air flow, warm days, cool nights and vibrant soil as the foundation of the quality of its product. Nuckolls, whose research focuses on the chemical differences between indoor and sun-grown cannabis, came up with the tools to evaluate that claim. “If I had to pick one place in the world to grow sun-grown cannabis, this would be it,” he said.

© Cigar

The endorsement carries scientific weight, as Nuckolls’ work addresses a gap that standard cannabis testing can hardly cover. Certificates of analysis measure a defined set of cannabinoids and terpenes, meaning two products grown under completely different conditions can appear identical on paper. His research shows that the picture is more complicated than that. “Sunlight creates complexity in the plant,” he said. “Sun grown cannabis represents a wider spectrum of compounds, more terpenes, more nuances, more chemistry that people value.”

The mechanism is evolutionary. Natural sunlight provides a full and dynamic light spectrum, including UV exposure, that plants have adapted to over millennia. Controlled indoor environments, however sophisticated, replicate only part of that equation.

The Kēkerengū site drew a close comparison with Northern California’s Humboldt County, one of the world’s most respected cannabis-growing regions. The two locations are located at roughly mirror-image latitudes on opposite sides of the equator and share a mountainous coastal profile. “This place is where you’d want to grow cannabis, like Humboldt County,” he said. “It’s the coast, the air is fresh and it’s mountainous. Nature does a lot of work in these areas, the growing conditions are ideal.”

For Puro, the visit was an independent validation of the company’s production philosophy since its inception. Marlborough’s sunshine hours are among the highest in New Zealand, and combined with the microclimate factors of the site where the farm is located, factors Nuckolls described as conditions “that technology cannot reproduce”.

For more information:
clean
www.puro.co.nz

Continue Reading

Cannabis News

Kansas Officials Are Being Sued Over Raids Against Hemp Businesses

Published

on

By

“The lawsuit is a diversionary tactic from Indy Vapes and Abilene Vape and CBD making a business decision to ignore state law.”

By Maya Smith, Kansas Reflector

Three smoke and vapor stores are suing the state of Kansas, alleging Fourth Amendment violations in some of the raids in October.

The plaintiffs have filed against KBI Director Tony Mattivi, Attorney General Kris Kobach (R), KBI agents, local law enforcement and county attorneys. They allege illegal search and seizure and defective warrants.

The KBI and local law enforcement raided smoke and vapor shops in Concordia, Independence, Abilene, McPherson, Pratt, Salina, Topeka and Wichita late last year.

They were organized with the intention of making networks end lax enforcement of Kansas’ anti-marijuana and anti-THC lawsKobach stated in the press conference during the attacks.

The lawsuit alleges that officials confiscated the hemp-derived products under Kansas law on warrants between legal and illegal hemp products.

Smoke and vape shops say the warrants were flawed by failing to recognize that the types of hemp-derived products are legal in Kansas, with Indy Vapes’ orders from Independence stating that all THC derivatives are contraband.

The Kansas Controlled Substances Act states that industrial hemp and hemp-derived products are legal and not controlled substances if they contain less than 0.3 percent THC. Plaintiffs allege that they sell legal hemp products and purchase those products from established wholesalers.

Kobach’s office did not respond to repeated requests for comment for this story.

The stores said they lost thousands of dollars in inventory and that the seized inventory was probably destroyed. Mattivi said in a press conference during the raids that the KBI had sent the products to the seized laboratories for private testing.

According to the lawsuit, agents told employees not to film, boarded up the windows from the inside, and disconnected the store’s internet and store security cameras.

“The lawsuit is a diversionary tactic since Indy Vapes and Abilene Vape and CBD made a business decision to ignore state law, and now they want to blame law enforcement for what they knew was the likely outcome,” according to a KBI statement. “We will uphold our responsibility to enforce the laws of Kansas.”

The KBI said the warrants executed by agents gave them the authority to seize illegal products and contraband. The statement did not address the officers interfering with the recording.

This story was first published by the Kansas Reflector.

Photo elements courtesy of the user rawpixel and Philip Steffan.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Examining regulatory changes to hemp cultivation in state

Published

on

By

Over the decades, the legality of hemp cultivation in the United States has undergone some changes. In 1970, the Controlled Substances Act made the cultivation of hemp completely illegal, along with the definition of “hemp” as “marijuana.” This criminalized approach to hemp changed with the 2018 Farm Bill, which removed hemp from the definition of “marijuana” and allowed states to create their own hemp regulation programs. In the past year, there has been a change in hemp cultivation regulations at the state level, as well as a change in the federal legal definition of “hemp.” Both of these changes will likely affect hemp growers.

After passing the 2018 Farm Bill, the state of Ohio, through the Ohio Department of Agriculture (ODA), submitted its plan to the United States Department of Agriculture (USDA) to regulate the cultivation and processing of hemp. In the spring of 2020, the ODA began accepting applications for the cultivation and processing of hemp.

as was shared in a blog post last summer, language included in the state operating budget passed in June 2025 gave up ODA’s authority to regulate hemp cultivation in the state. On July 25, 2025, the ODA began the process of transferring hemp cultivation regulation to the USDA. As of January 1, 2026, if you are growing hemp in Ohio, you must be licensed through the USDA, and all ODA cultivation licenses are revoked. The ODA continues to regulate hemp processors. ODA has a web page explaining these changes which is available here. For further reading, the state operating budget, HB 96, is available here.

Federal changes to the legal definition of “hemp.”
When hemp cultivation was legalized in the 2018 Farm Bill, Congress defined “hemp” as “Cannabis sativa L. plant and any part of that plant, including seeds and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether or not grown, with a deltabin (THC)-9 tetrabin (THC)-9 tetrabin concentration in excess of 0.3 percent dry weight.” After passing the 2018 Farm Bill, however, Congress discovered that this definition of “hemp” created an unintended loophole. Although delta-9 THC is the main psychoactive compound found in both hemp and marijuana that can cause intoxication, it is not the only compound. Since legalization, hemp products have been sold that contain no more than 0.3 percent delta-9 THC, but contain other cannabinoids, such as delta-8 THC, that can cause intoxication if ingested.

To close this loophole to allow for intoxicating hemp products, Congress changed the definition of hemp in HR 5371, which became law on November 12, 2025. The federal definition of hemp is now “Cannabis sativa L. plant and any part of that plant, including its seeds and all derivatives, extracts, isomers, isomers, isomers, acids, salts, isomers, acids, salts, isomers and acids. Whether or not growing, with a total (THC) concentration (including tetrahydrocannabinolic acid (THCA)) of more than 0.3 percent by dry weight.” As a result, instead of regulating only the amount of delta-9 THC, federal law now regulates the total THC concentration of hemp and its components. Thus, growers with hemp plants with a total THC concentration of more than 0.3 percent would be in violation of federal law. Importantly, this definition also applies to industrial hemp, or “hemp grown for use as seed stalk, whole grain, oil, cake, nut, hull, or any other non-cannabinoid derivative.” The new definition of hemp will go into effect one year after the law is signed, on November 12, 2026. The text of HR 5371 is available. here.

Source: The Ohio State University

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media